Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade

Overview of attention for article published in Frontiers in endocrinology, November 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 9,478 followers.

RT @FrontEndocrinol: New Research: Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade: Targeted radion…

20 Nov 2023

Reply Repost Favourite

RT @FrontEndocrinol: New Research: Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade: Targeted radion…

20 Nov 2023

Reply Repost Favourite

New Research: Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade: Targeted radionuclide therapy plays an increasingly important role in managing endocrine-related tumors and significantly advances… https://t.co/wcYmVqSg

20 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.